TMPA 是一种核受体 Nur77 和 LKB1 相互作用拮抗剂。

Glycogen phosphorylase-IN-1 is a selective and potent inhibitor of human hepatic glycogen phosphorylase (hlGPa) with inhibitory effects on hlGPa activity and on hepatocyte glycogen-derived glucose production, and can be used in the study of type 2 diabetes mellitus and canine lupus.

Lipopolysaccharides, Escherichiacoli (E. coli O111:B4) are derived from Escherichia coli O111:B4 and are a unique component of the cell wall of Gram-negative bacteria. They are composed of three regions: lipid A, oligosaccharide core, and O-specific polysaccharide (O-antigen). Lipopolysaccharides, Escherichiacoli help maintain the integrity of the cell outer membrane and protect bacteria from bile salts and lipid antibiotics.